NDC properties for "AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT" (RxCUI 1597074)
About this data
The tables show NDC propoerties for AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT with the RxCUI 1597074
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT (RxCUI 1597074)
| MMSL_CODE | BD22848 |
|---|---|
| MMSL_CODE | BN59773 |
| NDA | NDA021015 |
| RxCUI | 1597074 |
| SPL_SET_ID | d466910c-9a76-44e8-8759-4717ec2c591f |
| Prescribable Synonym | AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT |
| RXNAV_STR | AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT |
| RxNorm Name | 60 ACTUAT testosterone 12.5 MG/ACTUAT Topical Gel [Androgel] |
| RxNorm Synonym | AndroGel 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT |
| Related queries | Interactions (for RxCUI 1597074) |
NDC Properties
NDC Item 00051848833
| NDC 9 | 0051-8488 |
|---|---|
| NDC 10 | 0051-8488-33 |
| NDC Item | 00051848833 |
| Packaging | 75 g in 1 BOTTLE, PUMP |
| DCSA | CIII |
| FDA SPL set id | 616838 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |
| Related queries | Properties for NDC 9 0051-8488 |
NDC Item 00051848888
| NDC 9 | 0051-8488 |
|---|---|
| NDC 10 | 0051-8488-88 |
| NDC Item | 00051848888 |
| Packaging | 2 BOTTLE, PUMP in 1 CARTON (0051-8488-88) / 75 g in 1 BOTTLE, PUMP (0051-8488-33) |
| DCSA | CIII |
| FDA SPL set id | 616838 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |
| Related queries | Properties for NDC 9 0051-8488 |
NDC Item 00051848833
| NDC 9 | 0051-8488 |
|---|---|
| NDC 10 | 0051-8488-33 |
| NDC Item | 00051848833 |
| Packaging | 75 g in 1 BOTTLE, PUMP |
| DCSA | CIII |
| FDA SPL set id | 616838 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |
| Related queries | Properties for NDC 9 0051-8488 |
NDC Item 00051848888
| NDC 9 | 0051-8488 |
|---|---|
| NDC 10 | 0051-8488-88 |
| NDC Item | 00051848888 |
| Packaging | 2 BOTTLE, PUMP in 1 CARTON (0051-8488-88) / 75 g in 1 BOTTLE, PUMP (0051-8488-33) |
| DCSA | CIII |
| FDA SPL set id | 616838 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |
| Related queries | Properties for NDC 9 0051-8488 |